Table 3.
Fasting glucose | 2-h glucose | Fasting insulin | 2-h insulin | HOMA-IR | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Model | β | SE | β | SE | β | SE | β | SE | β | SE | |
1 | Age | 0.026* | 0.012 | 0.13* | 0.042 | 0.94 | 0.90 | 14.378* | 5.86 | 0.056 | 0.038 |
2 | Model 1 + Hispanic ethnicity | 0.029* | 0.013 | 0.13* | 0.044 | 0.59 | 0.92 | 12.903* | 6.14 | 0.047 | 0.041 |
3 | Model 2 + medication use | 0.029* | 0.013 | 0.13* | 0.043 | 0.47 | 0.80 | 12.864* | 6.21 | 0.034 | 0.036 |
4 | Model 3 + exceeded the Institute of Medicine’s gestational weight gain recommendation | 0.025 | 0.014 | 0.14* | 0.045 | 0.080 | 0.79 | 13.755* | 6.50 | 0.018 | 0.037 |
5 | Model 4 + breastfeeding | 0.029* | 0.014 | 0.14* | 0.047 | 0.30 | 0.83 | 12.785 | 6.69 | 0.032 | 0.039 |
6 | Model 5 + randomized group | 0.028* | 0.013 | 0.14* | 0.046 | 0.14 | 0.82 | 12.509 | 6.77 | 0.029 | 0.039 |
P < 0.05.
HOMA-IR, homeostasis model assessment of insulin resistance.